2C-Bu
| Clinical data | |
|---|---|
| Other names | 2,5-Dimethoxy-4-butylphenethylamine; 4-Butyl-2,5-dimethoxyphenethylamine; 2C-BU |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C14H23NO2 |
| Molar mass | 237.343 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2C-Bu, also known as 2,5-dimethoxy-4-butylphenethylamine, is a chemical compound of the phenethylamine and 2C families. It has been said by Daniel Trachsel to be completely unknown. 2C-Bu is the 2C analogue of the DOx derivative DOBU, which is active but does not appear to have psychedelic-type effects in either animals or humans.
2C-Bu has several notable skeletal isomers, including 2C-iBu, 2C-tBu, and 2C-sBu. 2C-iBu and 2C-tBu are both active and produce hallucinogen-type effects in animals and/or humans. This is in spite of 2C-tBu being predicted to be inactive and DOTB (the DOx analogue of 2C-tBu) being inactive as a hallucinogen in animals and humans. 2C-iBu may have reduced hallucinogenic potency than other 2C drugs and is being developed as a potential anti-inflammatory medication.